https://www.nature.com/articles/s41586-023-06623-2
Treatment with the oncolytic herpes virus CAN-3110 is associated with improved survival responses in patients with recurrent glioblastoma, particularly in individuals who are seropositive for HSV1.
Create an account or login to join the discussion